|
|
Article: Alder Biopharmaceuticals Announces Expanded Collaboration With Schering-Plough.
- Article from:
- Business Wire
- Article date:
- June 8, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Therapeutic Monoclonal Antibodies Generated From Antibody Identification & Production Technologies Selected as Lead Candidates
BOTHELL, Wash. -- Alder Biopharmaceuticals, Inc., an emerging antibody therapeutics company, today announced the expansion of its collaborative alliance with leading pharmaceutical company Schering-Plough Corporation (NYSE: SGP). The collaboration continues to be successful in identifying numerous high quality therapeutic monoclonal antibody lead candidates.
Candidates with potential applications to Central Nervous System (CNS) disorders are being identified through the application of Alder's innovative high throughput antibody ...
Related newspaper, magazine, and journal articles:
|
|
Article: Alder Biopharmaceuticals Appoints Clay B. Siegall, ...
Business Wire;
April 19, 2006 ;
700+ words
...BOTHELL, Wash. -- Alder Biopharmaceuticals Inc., an early-stage antibody therapeutics ... 2920 or litton@alderbio.com. About Alder Founded in January 2004, Alder Biopharmaceuticals uniquely identifies, develops, and manufactures ...
|
|